Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/20/2017 07/21/2017 07/24/2017 07/25/2017 07/26/2017 Date
33.54(c) 33.48(c) 33.32(c) 33.1(c) 32.89 Last
16 954 528 12 024 404 14 761 837 19 787 519 15 723 574 Volume
-0.24% -0.18% -0.48% -0.66% -0.63% Change
More quotes
Financials ($)
Sales 2017 52 763 M
EBIT 2017 19 898 M
Net income 2017 10 910 M
Debt 2017 23 332 M
Yield 2017 3,87%
Sales 2018 54 115 M
EBIT 2018 20 931 M
Net income 2018 12 016 M
Debt 2018 13 482 M
Yield 2018 4,09%
P/E ratio 2017 16,80
P/E ratio 2018 14,99
EV / Sales2017 4,18x
EV / Sales2018 3,89x
Capitalization 197 115 M
More Financials
Company
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines.It operates through the following business segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global... 
Sector
Pharmaceuticals
Calendar
08/01 | 12:45pmEarnings Release
More about the company
Surperformance© ratings of Pfizer
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER
10:29a PFIZER : Second US infliximab biosimilar launched at 35% discount to J&Js Remica..
09:50a PFIZER : Merck and Pfizer Collaborate with Corning
07/25 PFIZER : The Hill - Discussion
07/25 VIIV HEALTHCARE : Announces Superior Efficacy of Dolutegravir Versus Lopinavir/R..
07/25 PFIZER : Backed by partners at Pfizer, eFFECTOR brings its VC total to $150M as ..
07/25 PFIZER : Corning, with assists from Pfizer and Merck, plans $500M pharma glass p..
07/25 PFIZER : Phase II Study Results Showed Comparable Viral Suppression Rates at 96 ..
07/25 PFIZER : Announces Positive Top-Line Results From Comparative Reflections B73910..
07/25DJSamsung Enters U.S. Drug Market -- WSJ
07/24 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
More news
Sector news : Pharmaceuticals - NEC
03:30pDJGLAXOSMITHKLINE : Glaxo Ditches Raft of R&D Projects to Focus on Best Prospects ..
12:47pDJGLAXOSMITHKLINE : Sharpens R&D, Axes 30 Research Programs
07/25DJGlaxoSmithKline Names Former Wal-Mart Executive as Chief Digital and Technolo..
07/25DJELI LILLY AND : to Delay Arthritis Drug Application -- Market Talk
07/25DJABBVIE : Jury Backs AbbVie Payment -- WSJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on PFIZER 
2016Expectation of a turn-around
2016Back on a long term support level
More Strategies
Latest Tweets
05:26pThese 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now: Motley .. 
12:03aAdviser charged with insider trading on Pfizer-King deal pleads guilty  
07/253 Things In Biotech You Should Learn Today: July 25, 2017  
07/25Samsung Leaps Into Its First U.S. Biosimilars Battle  
07/25GlaxoSmithKline's Breo inhaler tops the list of RX drug advertising so far th.. 
More tweets
Qtime:338
News from SeekingAlpha
03:32a 2nd Quarter Review
07/25 3 THINGS IN BIOTECH YOU SHOULD LEARN : July 25, 2017
07/25 Samsung Leaps Into Its First U.S. Biosimilars Battle
07/25 BIOTECH BONANZA : The Next Leg Up
07/25 Gilead Puts Up The Good Fight Once Again
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 37,4 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
Ole Isacson Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER1.91%197 115
JOHNSON & JOHNSON14.47%355 263
NOVARTIS7.35%220 651
ROCHE HOLDING LTD.4.30%220 599
MERCK AND COMPANY5.93%170 565
SANOFI7.50%121 268